Publications by authors named "Alison Pedley"

Claim this Profile
I
Impact of differences between interim and post-interim analysis populations on outcomes of a group sequential trial: Example of the MOVe-OUT study.
Yoseph Caraco, Matthew G Johnson, Joseph A Chiarappa, Brian M Maas, Julie A Stone, Alison Pedley

Clin Trials· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18-49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factors.
Laura L Hammitt, Dean Quinn, Ewa Janczewska, Francisco J Pasquel, Richard Tytus, Alison Pedley

Hum Vaccin Immunother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economizing comparative Poisson clinical trials of multiple experimental treatments by testing against the same control.
Joseph A Chiarappa, Donald R Hoover, Alison Pedley

Stat Methods Med Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU).
Randall Severance, Howard Schwartz, Ron Dagan, Laurie Connor, Jianing Li, Alison Pedley

Hum Vaccin Immunother· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of V114, a 15-valent Pneumococcal Conjugate Vaccine, Compared with 13-valent Pneumococcal Conjugate Vaccine in Japanese Adults Aged ≥65 Years: Subgroup Analysis of a Randomized Phase III Trial (PNEU-AGE).
Hiroyuki Kishino, Miyuki Sawata, Rie Igarashi, Masayoshi Shirakawa, Alison Pedley

Jpn J Infect Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV.
Lerato Mohapi, Yvett Pinedo, Olayemi Osiyemi, Khuanchai Supparatpinyo, Winai Ratanasuwan, Alison Pedley

AIDS· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18-49 Years With or Without Risk Factors for Pneumococcal Disease: A Randomized Phase 3 Trial (PNEU-DAY).
Laura L Hammitt, Dean Quinn, Ewa Janczewska, Francisco J Pasquel, Richard Tytus, Alison Pedley

Open Forum Infect Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molnupiravir for Covid-19 in Nonhospitalized Patients. Reply.
Carisa De Anda, Matthew G Johnson, Alison Pedley

N Engl J Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.
Angélica Jayk Bernal, Monica M Gomes da Silva, Dany B Musungaie, Evgeniy Kovalchuk, Antonio Gonzalez, Alison Pedley

N Engl J Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lot-to-lot consistency, safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in healthy adults aged ≥50 years: A randomized phase 3 trial (PNEU-TRUE).
Jakub K Simon, Nina Breinholt Staerke, Maria Hemming-Harlo, Stacey Layle, Ron Dagan, Alison Pedley

Vaccine· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE).
Heather L Platt, Jose F Cardona, Miwa Haranaka, Howard I Schwartz, Silvia Narejos Perez, Alison Pedley

Vaccine· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by sequential PPSV23 vaccination in healthy adults aged ≥50 years: A randomized phase III trial (PNEU-PATH).
Joon-Young Song, Chih-Jen Chang, Charles Andrews, Javier Diez-Domingo, Myoung-Don Oh, Alison Pedley

Vaccine· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association of non-alcoholic fatty liver disease and cardiac structure and function-Framingham Heart Study.
Laura S Chiu, Alison Pedley, Joseph M Massaro, Emelia J Benjamin, Gary F Mitchell

Liver Int· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: 12-Month Observational Data From the Randomized Phase III Trial, MODIFY II.
Ellie J C Goldstein, Diane M Citron, Dale N Gerding, Mark H Wilcox, Lori Gabryelski, Alison Pedley

Clin Infect Dis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing Liver Fat Is Associated With Incident Cardiovascular Risk Factors.
Katherine T Brunner, Alison Pedley, Joseph M Massaro, Udo Hoffmann, Emelia J Benjamin

Clin Gastroenterol Hepatol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing liver fat is associated with progression of cardiovascular risk factors.
Katherine T Brunner, Alison Pedley, Joseph M Massaro, Udo Hoffmann, Emelia J Benjamin

Liver Int· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults.
Helen L Stacey, Jeffrey Rosen, James T Peterson, Angela Williams-Diaz, Vanita Gakhar, Alison Pedley

Hum Vaccin Immunother· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: A secondary analysis.
Robert M Wilechansky, Alison Pedley, Joseph M Massaro, Udo Hoffmann, Emelia J Benjamin

Liver Int· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver Fat Is Associated With Markers of Inflammation and Oxidative Stress in Analysis of Data From the Framingham Heart Study.
Zachary P Fricker, Alison Pedley, Joseph M Massaro, Ramachandran S Vasan, Udo Hoffmann

Clin Gastroenterol Hepatol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bezlotoxumab Is Associated With a Reduction in Cumulative Inpatient-Days: Analysis of the Hospitalization Data From the MODIFY I and II Clinical Trials.
Anirban Basu, Vimalanand S Prabhu, Mary Beth Dorr, Yoav Golan, Erik R Dubberke, Alison Pedley

Open Forum Infect Dis· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A simple clinical model predicts incident hepatic steatosis in a community-based cohort: The Framingham Heart Study.
Michelle T Long, Alison Pedley, Joseph M Massaro, Udo Hoffmann, Jiantao Ma

Liver Int· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visceral and Intrahepatic Fat Are Associated with Cardiometabolic Risk Factors Above Other Ectopic Fat Depots: The Framingham Heart Study.
Jane J Lee, Alison Pedley, Udo Hoffmann, Joseph M Massaro, Daniel Levy

Am J Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Associations of Pericardial and Intrathoracic Fat With Progression of Coronary Artery Calcium (from the Framingham Heart Study).
Jane J Lee, Alison Pedley, Udo Hoffmann, Joseph M Massaro, Christopher J O'Donnell

Am J Cardiol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection.
Vimalanand S Prabhu, Oliver A Cornely, Yoav Golan, Erik R Dubberke, Sebastian M Heimann, Alison Pedley

Clin Infect Dis· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections.
Matthew Sims, Valeri Mariyanovski, Patrick McLeroth, Wayne Akers, Yu-Chieh Lee, Alison Pedley

J Antimicrob Chemother· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis